Emmessar Biotech Complete Financial Statements
EMMESSA • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Emmessar Biotech (EMMESSA).
Downloads include all available records across all periods.
For market performance, see the
EMMESSA stock price today
.
Profitability Ratios
EBITDA Margin
33.33%
2025 data
Operating Margin
-156.00%
2025 data
Balance Sheet Ratios
Current Ratio
7.00
2025 data
Debt to Equity
1.13
2025 data
Equity Ratio
88.89%
2025 data
Asset Turnover
0.33
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-33.3%
Year-over-Year
Equity Growth
+14.3%
Year-over-Year
Operating Cash Flow Growth
-100.0%
Year-over-Year
Investing Cash Flow Growth
+100.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 | 3 | 3 | 3 | 2 | 9 | 5 | 2 | 3 | 4 | 2 | 2 |
| Expenses | 2 | 2 | 2 | 2 | 1 | 6 | 4 | 1 | 2 | 2 | 2 | 2 |
| EBITDA | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 0 |
| Operating Profit Margin % | -331.00% | -156.00% | -195.00% | -68.00% | -245.00% | 12.00% | -12.00% | -102.00% | -32.00% | 9.00% | 1.00% | -7.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 1 | -1 | 0 |
| Tax | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | -1 | 0 |
| Earnings Per Share (₹) | 0.40 | 0.63 | 1.50 | 0.99 | 0.94 | 2.90 | 1.51 | 1.05 | 1.83 | 2.36 | -0.93 | -0.24 |
Related Pages for Emmessar Biotech
Additional stock information and data for EMMESSA
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 9 | 9 | 8 | 7 | 8 | 6 | 5 | 4 | 3 | 2 | 2 |
| Current Assets | 7 | 7 | 6 | 5 | 5 | 3 | 2 | 1 | 1 | 1 | 1 |
| Fixed Assets | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 7 | 7 | 6 | 5 | 6 | 4 | 3 | 2 | 2 | 2 | 1 |
| LIABILITIES | |||||||||||
| Total Liabilities | 9 | 9 | 8 | 7 | 8 | 6 | 5 | 4 | 3 | 2 | 2 |
| Current Liabilities | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 8 | 7 | 7 | 6 | 6 | 4 | 4 | 3 | 2 | 1 | 1 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 3 | 2 | 2 | 1 | 1 | -1 | -2 | -2 | -3 | -4 | -4 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 1 | 0 | 2 | 1 | 1 | 0 | 1 | 1 | 0 | 0 |
| Investing Activities | 0 | -1 | -1 | -3 | 0 | -1 | 0 | -1 | -1 | -1 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |